MYRIAD GENETICS INC.

Myriad Genetics to Release Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024

21 2 2024 13:05:00 提供 Nasdaq GlobeNewswire

Myriad Genetics Appoints Dallas Reed, MD, FACOG, FACMG as Principal Medical Advisor of Women’s Health

15 2 2024 13:05:00 提供 Nasdaq GlobeNewswire

Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics

01 2 2024 06:25:00 提供 Nasdaq GlobeNewswire

Myriad Genetics Names George Daneker Jr., MD, as President and Chief Clinical Officer of Oncology

30 1 2024 14:00:00 提供 Nasdaq GlobeNewswire

Myriad Genetics to Acquire Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics

18 1 2024 15:10:00 提供 Nasdaq GlobeNewswire

Myriad Genetics Applauds New Germline Testing Guideline for Patients with Breast Cancer from ASCO-SSO

09 1 2024 13:05:00 提供 Nasdaq GlobeNewswire

Myriad Genetics to Present at 42nd Annual J.P. Morgan Healthcare Conference

03 1 2024 13:05:00 提供 Nasdaq GlobeNewswire

Myriad Genetics Chief Financial Officer Bryan Riggsbee Retires; Scott Leffler Appointed as Successor; Reiterates Previously Issued Financial Guidance

21 12 2023 05:30:00 提供 Nasdaq GlobeNewswire

Myriad Genetics Establishes Comprehensive Pan-Cancer Research Platform to Advance Patient Care

20 12 2023 05:00:00 提供 Nasdaq GlobeNewswire

Myriad Genetics Celebrates One Million SneakPeek® Results Shared with Expectant Parents

20 11 2023 13:05:00 提供 Nasdaq GlobeNewswire

Myriad Genetics and Personalis Partner to Market Solutions to Pharma Customers

16 11 2023 13:05:00 提供 Nasdaq GlobeNewswire

Myriad Genetics to Participate in Stephens Annual Investment Conference

09 11 2023 04:00:00 提供 Nasdaq GlobeNewswire

Myriad Genetics Announces Pricing of Upsized Offering of Common Stock

08 11 2023 18:20:00 提供 Nasdaq GlobeNewswire

Myriad Genetics Announces Proposed Offering of $100 Million of Shares of Common Stock

08 11 2023 13:10:56 提供 Nasdaq GlobeNewswire

Myriad Genetics Reports Third Quarter 2023 Financial Results; Generates Double-Digit Revenue Growth; Raises 2023 Revenue Guidance and Introduces 2024 Revenue Guidance

06 11 2023 13:05:01 提供 Nasdaq GlobeNewswire

Myriad Genetics Appoints Sam Raha as Chief Operating Officer

01 11 2023 06:00:00 提供 Nasdaq GlobeNewswire

Myriad Genetics to Release Third Quarter Financial Results on November 6, 2023

31 10 2023 13:05:00 提供 Nasdaq GlobeNewswire

QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancer

26 10 2023 05:00:00 提供 Nasdaq GlobeNewswire

New Myriad Genetics Survey Shows Breast Cancer Risk Factors Are Misunderstood

28 9 2023 04:00:00 提供 Nasdaq GlobeNewswire

Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

19 9 2023 06:00:00 提供 Nasdaq GlobeNewswire